TELADOC HEALTH, INC. Revenue
TELADOC HEALTH, INC. (TDOC) reported Revenue of $606.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-30
- TELADOC HEALTH, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $606.93M, a 3.95% decline year-over-year.
- TELADOC HEALTH, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $613.85M, a 2.47% decline year-over-year.
- TELADOC HEALTH, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $642.27M, a 0.28% increase year-over-year.
- TELADOC HEALTH, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $626.44M, a 2.20% decline year-over-year.
- TELADOC HEALTH, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $2.53B, a 1.54% decline from fiscal 2024.
- TELADOC HEALTH, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $2.57B, a 1.26% decline from fiscal 2023.
- TELADOC HEALTH, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $2.60B, a 8.13% increase from fiscal 2022.
- TELADOC HEALTH, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $2.41B, a 18.41% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $606.93M 10-Q · filed 2026-07-30 | $1.22B 10-Q · filed 2026-07-30 | $1.86B derived: sum of 3 quarters · filed 2026-07-30 | $2.49B derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $613.85M 10-Q · filed 2026-04-30 | $1.26B derived: sum of 2 quarters · filed 2026-04-30 | $1.88B derived: sum of 3 quarters · filed 2026-04-30 | $2.51B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $642.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.27B derived: sum of 2 quarters · filed 2026-02-26 | $1.90B derived: sum of 3 quarters · filed 2026-07-30 | $2.53B 10-K · filed 2026-02-26 |
| 2025-09-30 | $626.44M 10-Q · filed 2025-10-30 | $1.26B derived: sum of 2 quarters · filed 2026-07-30 | $1.89B 10-Q · filed 2025-10-30 | $2.53B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $631.90M 10-Q · filed 2026-07-30 | $1.26B 10-Q · filed 2026-07-30 | $1.90B derived: sum of 3 quarters · filed 2026-07-30 | $2.54B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $629.37M 10-Q · filed 2026-04-30 | $1.27B derived: sum of 2 quarters · filed 2026-04-30 | $1.91B derived: sum of 3 quarters · filed 2026-04-30 | $2.55B derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $640.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.28B derived: sum of 2 quarters · filed 2026-02-26 | $1.92B derived: sum of 3 quarters · filed 2026-02-26 | $2.57B 10-K · filed 2026-02-26 |
| 2024-09-30 | $640.51M 10-Q · filed 2025-10-30 | $1.28B derived: sum of 2 quarters · filed 2025-10-30 | $1.93B 10-Q · filed 2025-10-30 | $2.59B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $642.44M 10-Q · filed 2025-07-30 | $1.29B 10-Q · filed 2025-07-30 | $1.95B derived: sum of 3 quarters · filed 2026-02-26 | $2.61B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $646.13M 10-Q · filed 2025-05-01 | $1.31B derived: sum of 2 quarters · filed 2026-02-26 | $1.97B derived: sum of 3 quarters · filed 2026-02-26 | $2.62B derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $660.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.32B derived: sum of 2 quarters · filed 2026-02-26 | $1.97B derived: sum of 3 quarters · filed 2026-02-26 | $2.60B 10-K · filed 2026-02-26 |
| 2023-09-30 | $660.24M 10-Q · filed 2024-10-31 | $1.31B derived: sum of 2 quarters · filed 2024-10-31 | $1.94B 10-Q · filed 2024-10-31 | $2.58B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $652.41M 10-Q · filed 2024-08-01 | $1.28B 10-Q · filed 2024-08-01 | $1.92B derived: sum of 3 quarters · filed 2025-02-27 | $2.53B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $629.24M 10-Q · filed 2024-04-26 | $1.27B derived: sum of 2 quarters · filed 2025-02-27 | $1.88B derived: sum of 3 quarters · filed 2025-02-27 | $2.47B derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $637.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.25B derived: sum of 2 quarters · filed 2025-02-27 | $1.84B derived: sum of 3 quarters · filed 2025-02-27 | $2.41B 10-K · filed 2025-02-27 |
| 2022-09-30 | $611.40M 10-Q · filed 2023-10-27 | $1.20B derived: sum of 2 quarters · filed 2023-10-27 | $1.77B 10-Q · filed 2023-10-27 | $2.32B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $592.38M 10-Q · filed 2023-07-28 | $1.16B 10-Q · filed 2023-07-28 | $1.71B derived: sum of 3 quarters · filed 2024-02-23 | $2.23B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $565.35M 10-Q · filed 2023-05-02 | $1.12B derived: sum of 2 quarters · filed 2024-02-23 | $1.64B derived: sum of 3 quarters · filed 2024-02-23 | $2.14B derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $554.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $1.08B derived: sum of 2 quarters · filed 2024-02-23 | $1.58B derived: sum of 3 quarters · filed 2024-02-23 | $2.03B 10-K · filed 2024-02-23 |
| 2021-09-30 | $521.66M 10-Q · filed 2022-11-02 | $1.02B derived: sum of 2 quarters · filed 2022-11-02 | $1.48B 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $503.14M 10-Q · filed 2022-08-03 | $956.81M 10-Q · filed 2022-08-03 | ||
| 2020-12-31 | $1.09B 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |